Wenjiao Song

Wenjiao Song is a highly experienced analytical scientist with a robust background in drug development and analytical methodologies. Currently serving as Group Lead in Analytical R&D at Ascendia since May 2020, Wenjiao Song has contributed to project management and product development strategies. Previous roles include Senior Scientist at Pfizer, where analytical methods for nanoparticle formulations were developed, and Analytical Scientist at Teva Pharmaceuticals, focusing on HPLC/UPLC analysis and drug characterization. Wenjiao Song's extensive research background includes tenure as Senior Research Scientist at Lucerna, Inc., a postdoctoral associate at Weill Cornell Medical College, and multiple research positions at the University at Buffalo, complemented by a Ph.D. in Chemistry. Academic credentials include a Master's in Analytical Chemistry and a Bachelor's in Applied Chemistry from Beijing Normal University.